GlaxoSmithKline Biologicals S.A.
PolandAll medications by this manufacturer
-
Boostrix
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid No input provided tetanus toxoid No input provided Bordetella pertussis antigens No input provided ATC: J07AJ52
-
Boostrix polio
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid > or equal to 2 IU (2.5 Lf) aluminum phosphate 0.2 mg Al 3+ inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D tetanus toxoid > or equal 20 IU (5 Lf) aluminum hydroxide hydrate 0.3 mg Al 3+ Bordetella pertussis antigens 8 mcg + 8 mcg + 2.5 mcg ATC: J07CA02
-
Engerix b
Form: suspension for injection
Active substance Dosage Hepatitis B surface antigen HBsAg 20 mcg/ml ATC: J07BC01
-
Engerix b
Form: suspension for injection
Active substance Dosage Hepatitis B surface antigen HBsAg 10 mcg/0.5 ml ATC: J07BC01
-
Havrix 720 junior
Form: suspension for injection
Active substance Dosage hepatitis A virus, strain HM175 inactivated not less than 720 ELISA units ATC: J07BC02
-
Havrix adult
Form: suspension for injection
Active substance Dosage hepatitis A virus, strain HM175 inactivated not less than 1440 ELISA units ATC: J07BC02
-
Infanrix - ipv + hib
Form: powder and suspension for preparation of injection suspension
Active substance Dosage diphtheria toxoid No input provided tetanus toxoid No input provided Bordetella pertussis antigens No input provided inactivated poliovirus types 1, 2 and 3 No input provided Haemophilus b polysaccharide conjugated with tetanus toxoid No input provided ATC: J07CA06
-
Infanrix ipv
Form: suspension for injection
Active substance Dosage inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D Diphtheria toxoid or equal to 30 IU Tetanus toxoid or equal to 40 IU pertussis antigens 25 mcg + 25 mcg + 8 mcg ATC: J07CA02
-
Priorix
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage live attenuated measles virus strain Schwarz not less than 10^3.0 CCID50 live attenuated mumps virus (RIT 4385 strain derived from Jeryl Lynn strain) not less than 10^3.7 CCID50 live attenuated rubella virus Wistar RA 27/3 strain not less than 10^3.0 CCID50 ATC: J07BD52
-
Priorix-tetra
Form: solution for injection, powder and solvent for preparation of solution for injection in prefilled syringe
Active substance Dosage measles mumps rubella and varicella vaccine live No input provided ATC: J07BD54
-
Priorix-tetra
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage measles mumps rubella and varicella vaccine live No input provided ATC: J07BD54
-
Varilrix
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage Varicella zoster virus Oka strain not less than 2000 PFU ATC: J07BK01